Engelstad Family Foundation Pledges $10 million Gift to Advance Roseman University’s College of Medicine

- Donation leads $66 million campaign -

LAS VEGAS, Sept. 7, 2017 /PRNewswire-USNewswire/ -- Roseman University College of Medicine today announced a $10 million pledge gift from the Engelstad Family Foundation to help advance the opening of Nevada's first private, non-profit, MD-granting medical school in Summerlin.

The donation, the largest in Roseman University's history, kicks off "Breakthrough in Medicine!," a $66 million fundraising campaign that will ensure the College of Medicine fulfills its mission to improve the health of the communities in southern Nevada by providing funding to hire the critical faculty and staff needed as it continues through the rigorous accreditation process. The College of Medicine is currently an applicant with the Liaison Committee on Medical Education (LCME) and has a goal to achieve accreditation to enroll its first class of 64 students in the summer of 2019.

"In addition to the institutional resources provided by Roseman University, this pledged gift is a significant step in our effort to raise the $66 million needed to establish a premier private, MD-granting medical school that will help Nevada communities overcome the chronic shortage of physicians and improve healthcare outcomes," said Mark A. Penn, MD, MBA, founding dean of the Roseman University College of Medicine.

"As a non-profit, private medical school, built without the support of state funding, we are extremely grateful for the generosity and support of the Engelstad Family Foundation and the many business and community members who have also embraced our mission and vision, and supported the College with philanthropic gifts. Additional support is needed as we work towards our goal of raising $66 million," added Penn.

In making the donation, the Engelstad Family Foundation stated, "The Engelstad Family Foundation applauds the work of Roseman University College of Medicine and their endeavor to raise $66 million to ultimately improve healthcare in Southern Nevada through their 'Breakthrough in Medicine' campaign for Roseman University's medical school in Summerlin – the first of its kind in Nevada."

According to Roseman University President Renee Coffman, PhD, in making this landmark pledge gift, the Engelstad Family Foundation will help transform the healthcare landscape in Nevada. "Roseman University and the Engelstad Family Foundation have a shared vision for our state's future – a Nevada where every resident has access to high-quality primary care and medical specialties," said Coffman.

About the Roseman University College of Medicine
Roseman University began building the foundation for its MD-granting College of Medicine in 2010 through the establishment of medical research programs. On December 13, 2013, the Board of Trustees of Roseman University unanimously approved the university's plan to develop an allopathic medical school in Southern Nevada. The College of Medicine is housed at Roseman University's Summerlin campus.

About Roseman University of Health Sciences
Founded in Henderson, Nevada in 1999, Roseman University of Health Sciences is a non-profit, private institution of higher learning training the next generation of undergraduate and graduate level health care professionals that serve, collaborate and set new standards in their communities and within their professions. With campuses in Henderson, Summerlin in Nevada and South Jordan, Utah, the University is comprised of the College of Dental Medicine, offering an Advanced Education in Orthodontics and Dentofacial Orthopedics/MBA residency, Advance Education in General Dentistry residency and Doctor of Dental Medicine program; College of Pharmacy, offering a Doctor of Pharmacy and Professional Continuing Education; College of Nursing, offering a Bachelor of Science in Nursing, Accelerated Bachelor of Science in Nursing and RN to BSN; and an healthcare focused MBA program. Roseman University of Health Sciences will also offer a Doctor of Medicine through its College of Medicine once it becomes accredited. More than 4,000 Roseman graduates are caring for patients, conducting research, and engaged in public health and policy in Nevada, Utah and across the country. Roseman University is regionally accredited by the Northwest Commission on Colleges and Universities.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/engelstad-family-foundation-pledges-10-million-gift-to-advance-roseman-universitys-college-of-medicine-300515862.html

SOURCE Roseman University of Health Sciences

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017

HACKENSACK, N.J., Sept. 7, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the first quarter ended July 31, 2017, on Thursday, September 14, 2017, after market close.

The company will host a conference call to discuss the results that day at 5:00 p.m. EST (2:00 p.m. PST). To participate in the call, please call 866-682-6100 (domestic) or 404-267-0373 (international) ten minutes ahead of the call and give the verbal reference "Champions Oncology."

A replay of the call will be available on the Investor tab of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs.  The Company's TumorGraft technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments, or TumorGrafts, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen.  The Company uses this technology in conjunction with related services to offer solutions for two customer groups:  Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through Champions' Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.

View original content:http://www.prnewswire.com/news-releases/champions-oncology-to-announce-first-quarter-financial-results-on-thursday-september-14-2017-300515798.html

SOURCE Champions Oncology, Inc.

Alcohol Justice Reports: Alcohol industry misleading the public about alcohol-related cancer risk

Study identifies "denying, distortion and distraction" as main strategies

SAN FRANCISCO, Sept. 7, 2017 /PRNewswire-USNewswire/ -- Alcohol Justice is reporting the release of a new study in the UK showing that the alcohol industry (AI) is misrepresenting evidence about the alcohol-related risk of cancer with activities that have parallels with those of the tobacco industry. The new research is published in the journal Drug and Alcohol Review.

Led by the London School of Hygiene & Tropical Medicine with the Karolinska Institutet, Sweden, the team analysed the information relating to cancer which appears on the websites and documents of nearly 30 alcohol industry organisations around the world between September 2016 and December 2016. Most of the organisational websites (24/26) showed some sort of distortion or misrepresentation of the evidence about alcohol-related cancer risk, with breast and colorectal cancers being the most common focus of misrepresentation

The most common approach involves presenting the relationship between alcohol and cancer as highly complex, with the implication or statement that there is no evidence of a consistent or independent link. Others include denying that any relationship exists or claiming inaccurately that there is no risk for light or 'moderate' drinking, as well discussing a wide range of real and potential risk factors, thus presenting alcohol as just one risk among many.

"This study exposes Big Alcohol's standard operating procedure - deny, distract and distort evidence of alcohol as a dangerous disease-causing agent," stated Bruce Lee Livingston, Executive Director / CEO of U.S-based Alcohol Justice. "It is further evidence that any and all health claims made by the alcohol industry are nothing more than marketing rhetoric making it culpable for fueling over-consumption and massive related harm worldwide."

According to the study, the researchers say policymakers and public health bodies should reconsider their relationships to these alcohol industry bodies, as the industry is involved in developing alcohol policy in many countries, and disseminates health information to the public.

Alcohol consumption is a well-established risk factor for a range of cancers, including oral cavity, liver, breast and colorectal cancers, and accounts for about 4% of new cancer cases annually in the UK1. There is limited evidence that alcohol consumption protects against some cancers, such as renal and ovary cancers, but in 2016 the UK's Committee on Carcinogenicity concluded that the evidence is inconsistent, and the increased risk of other cancers as a result of drinking alcohol far outweighs any possible decreased risk².

This new study analysed the information which is disseminated by 27 AI-funded organisations, most commonly 'social aspects and public relations organisations' (SAPROs), and similar bodies. The researchers aimed to determine the extent to which the alcohol industry fully and accurately communicates the scientific evidence on alcohol and cancer to consumers.

They analysed information on cancer and alcohol consumption disseminated by alcohol industry bodies and related organisations from English speaking countries, or where the information was available in English.

Through qualitative analysis of this information they identified three main industry strategies. Denying, or disputing any link with cancer, or selective omission of the relationship, Distortion: mentioning some risk of cancer, but misrepresenting or obfuscating the nature or size of that risk and Distraction: focussing discussion away from the independent effects of alcohol on common cancers.

Mark Petticrew, Professor of Public Health at the London School of Hygiene & Tropical Medicine and lead author of the study, said: "The weight of scientific evidence is clear - drinking alcohol increases the risk of some of the most common forms of cancer, including several common cancers. Public awareness of this risk is low, and it has been argued that greater public awareness, particularly of the risk of breast cancer, poses a significant threat to the alcohol industry. Our analysis suggests that the major global alcohol producers may attempt to mitigate this by disseminating misleading information about cancer through their 'responsible drinking' bodies."

A common strategy was 'selective omission' - avoiding mention of cancer while discussing other health risks or appearing to selectively omit specific cancers. The researchers say that one of the most important findings is that AI materials appear to specifically omit or misrepresent the evidence on breast and colorectal cancer. One possible reason is that these are among the most common cancers, and therefore may be more well-known than oral and oesophageal cancers.

When breast cancer is mentioned the researchers found that 21 of the organisations present no, or misleading, information on breast cancer, such as presenting many alternative possible risk factors for breast cancer, without acknowledging the independent risk of alcohol consumption.

Professor Petticrew said: "Existing evidence of strategies employed by the alcohol industry suggests that this may not be a matter of simple error. This has obvious parallels with the global tobacco industry's decades-long campaign to mislead the public about the risk of cancer, which also used front organisations and corporate social activities."

The researchers say the results are important because the alcohol industry is involved in conveying health information to people around the world. The findings also suggest that major international alcohol companies may be misleading their shareholders about the risks of their products, potentially leaving the industry open to litigation in some countries.

Professor Petticrew said: "Some public health bodies liaise with the industry organisations that we analysed. Despite their undoubtedly good intentions, it is unethical for them to lend their expertise and legitimacy to industry campaigns which mislead the public about alcohol-related harms. Our findings are also a clear reminder of the risks of giving the AI the responsibility of informing the public about alcohol and health.

"It has often been assumed that, by and large, the AI, unlike the tobacco industry, has tended not to deny the harms of alcohol. However, through its provision of misleading information it can maintain what has been called 'the illusion of righteousness' in the eyes of policymakers, while negating any significant impact on alcohol consumption and profits.

"It's important to highlight that if people drink within the recommended guidelines they shouldn't be too concerned when it comes to cancer. For accurate and accessible information on the risks, the public can visit the NHS website."

The authors acknowledge limitations of their study including that there are many other mechanisms and organisations through which industry disseminates health-related information which they did not examine, although it is unlikely that the messages would be different.

The researchers also say there is an urgent need to examine other industry websites, documents, social media and other materials in order to assess the nature and extent of the distortion of evidence, and whether it extends to other health information, for example, in relation to cardiovascular disease.

For more information or to request interviews please contact the London School of Hygiene & Tropical Medicine press office on +44(0)20 7927 2802 or email press@lshtm.ac.uk.

A copy of the paper is available upon request.

Notes to Editors

Publication

Mark Petticrew, Nason Maani Hessari ,Cécile knai and Elisabete Weiderpass. How alcohol industry organisations mislead the public about alcohol and cancer. Drug and Alcohol Review. DOI: 10.1111/dar.12596

1Cancer Research UK: Statistics on preventable cancers.

2Committee on Carcinogenicity of chemicals in food, consumer products and the environment (COC). Statement 2015/S2.

About the London School of Hygiene & Tropical Medicine

The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with more than 4,000 students and 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, is among the world's leading schools in public and global health, and was named University of the Year in the Times Higher Education Awards 2016. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. http://www.lshtm.ac.uk

View original content with multimedia:http://www.prnewswire.com/news-releases/alcohol-justice-reports-alcohol-industry-misleading-the-public-about-alcohol-related-cancer-risk-300515978.html

SOURCE Alcohol Justice

Nurses Nationwide Lend a Helping Hand at Bay Area Regional in the Aftermath of Hurricane Harvey

WEBSTER, Texas, Sept. 7, 2017 /PRNewswire/ -- Nurses from New Jersey, New York, California and Massachusetts made their way to Bay Area Regional Medical Center in the days after impact to relieve staff to get much needed rest and to begin the process of cleanup and rebuilding.

Bay Area Regional employees weathered the storm at the hospital for many days. Most slept in the hospital because of massive, widespread flooding. "Some essential staff was rescued by boat and by large vehicles when the flooding first began," said Stephen K. Jones, Jr., CEO of Bay Area Regional Medical Center. "Thanks to many folks, we were able to rescue and transport many staff to the hospital. Many of whom had significant water damage to their homes and vehicles."

Nurses from New Jersey landed at Ellington Field August 31 and have spent time helping at the hospital and volunteering to demo nurses flooded homes along with volunteering at shelters.

"I am humbled and in awe at the generosity and positive attitudes the wonderful community and staff of Bay Area Regional Medical Center have expressed toward us in light of the hardship they have endured," said Brenda Lima-Mattessich, RN from AtlantiCare in New Jersey. "I worked 18-20 hours a day during Hurricane Sandy, so I know what the nurses here are going through. Everyone has embraced us with humbleness and grace."

Vanessa Jones, RN from Capital Health in New Jersey commented, "We came here to help and we are leaving with a sense of family and relationships that we will have for years to come."

Bay Area Regional was "designed to withstand a category five hurricane with 225 mph winds and designed with the future mind in strength, quality and state-of-the-art equipment," said Monzer Hourani, CEO of Medistar Corp. "While other hospitals had to evacuate or stop accepting patients, Bay Area Regional remained open and was unaffected structurally by the storm. In fact, the National Guard delivered patients to our hospital." 

Relief efforts are still underway as the hospital welcomed nurses from Massachusetts on September 6 in the afternoon. "I am honored to have so many nurses from across the country ready to assist our staff in the recovery efforts after Hurricane Harvey," said Jones, Jr. "We are truly blessed by each person who got on an airplane to come to the Houston Bay Area and lend a helping hand to our wonderful community."

About Bay Area Regional Medical Center
Bay Area Regional Medical Center is committed to providing the highest quality medical care while making a difference in people's lives. Designed with a beautiful, soothing environment, Bay Area Regional offers some of the latest technology for physicians to provide advanced diagnostic and treatment techniques. Since opening in July 2014, Bay Area Regional has achieved the highest level Chest Pain Center Accreditation, is in pursuit of Level III Trauma Designation, and has achieved a Center of Excellence for Bariatric Surgery and Hidden Scar Breast Surgery. The hospital offers services such as heart and vascular services, general surgery, orthopedics, emergency services, surgical weight-loss, outpatient imaging, including 3D Mammography with a new Women's OB unit opening in September 2017. For more information, visit www.BARMC.us.

Contact: Abbey Lee
alee@BARMC.us 
832-585-7263 (cell)

 

View original content with multimedia:http://www.prnewswire.com/news-releases/nurses-nationwide-lend-a-helping-hand-at-bay-area-regional-in-the-aftermath-of-hurricane-harvey-300515985.html

SOURCE Bay Area Regional Medical Center

Red Cross Mobilizing in Advance of Historic and Powerful Hurricane Irma

Storm batters Caribbean and heads for Florida

WASHINGTON, Sept. 7, 2017 /PRNewswire-USNewswire/ -- The American Red Cross is mounting a massive response as Hurricane Irma — the most powerful Atlantic Ocean storm on record – remains a Category 5 hurricane with 175 mph winds expected to impact Florida as early as Friday. Irma has already caused destruction on many Caribbean island nations on its track toward the United States, and the Red Cross urges that those in the possible path of this storm monitor weather reports and get prepared or evacuate now.

In the Caribbean:
Hurricane Irma has already battered an estimated 1.2 million people in the Caribbean, and threatens millions more as it moves across the region. On the island of Barbuda, most of the buildings are damaged. Anguilla and St. Maarten also received major damage. Thousands of residents are without power and water, and there are major disruptions in phone and cell service. On Anguilla, the local Red Cross facility was severely damaged. In addition to the Red Cross Societies on the islands, numerous countries are helping, including the American Red Cross and Red Cross Societies in Canada, Italy, Spain, and Norway, as well as teams from the International Federation of the Red Cross and International Committee of the Red Cross.

In the U.S.:
In Puerto Rico and the U.S. Virgin Islands, some roads are damaged, phone and cell service is disrupted, and airports and ports are closed. In Puerto Rico, the Red Cross is on the ground helping and has sent in relief items such as blankets, personal hygiene items and cleaning supplies. More than half-a-million people are without power. More than 140 people spent Wednesday night in 20 shelters. On the U.S. Virgin Islands, almost 300 people spent Wednesday night in 6 shelters.

As the storm makes its way towards Florida, the Red Cross is getting supplies and trained workers in place to support sheltering and relief efforts.

  • The Red Cross is mobilizing hundreds of trained Red Cross disaster relief workers and is deploying truckloads of relief supplies.
  • Trailers of shelter supplies with enough cots and blankets for 120,000 people are on the way to help people impacted by Irma.
  • In addition, 100,000 ready-to-eat meals and as many as 120 emergency response vehicles are being mobilized.
  • The Red Cross is also working in close collaboration with government officials and community partners to coordinate potential response efforts.
  • In preparation for Hurricane Irma, the Red Cross has pre-positioned additional blood products in areas of the Southeast likely to be impacted by the storm over the upcoming days. Earlier this week, the Red Cross also shipped additional blood products to Puerto Rico to help ensure a sufficient supply remains available for our hospital partners on the island in the aftermath of this powerful storm.

Governors in Georgia, South Carolina and North Carolina have issued states of emergency for all three states, which could face impact from the storm sometime next week.

Hurricane Safety Steps
Find a shelter by visiting redcross.org or by downloading the free Red Cross Emergency App. The Emergency App also puts real-time information about the storm and hurricane safety tips at your fingertips. The app is available in app stores by searching for the American Red Cross or going to redcross.org/apps. You can also follow these safety steps:

Before the storm:

  • Continue listening to local area radio, NOAA radio or TV stations for the latest information and updates.
  • If your neighborhood is prone to flooding, be prepared to evacuate quickly if necessary.
  • Build an emergency kit that contains supplies for about three days.
  • Follow evacuation orders and do not attempt to return until officials say it is safe to do so.
  • Head for higher ground and stay there.
  • Stay away from floodwaters. If you come upon a flowing stream where water is above your ankles, stop, turn around and go another way.
  • Be especially cautious at night when it's harder to see flood danger.
  • Make sure you have a plan and supplies for your pets. Download the free Red Cross Pet First Aid App for emergency preparedness tips, a pet-friendly hotel locator and an animal hospital locator.

During the storm:

  • Stay indoors.
  • Don't walk on beaches, riverbanks or in flood waters.
  • Use flashlights in the dark if the power goes out. Do NOT use candles.
  • Turn off the power and water mains if instructed to do so by local authorities.
  • Don't forget your pets. Bring them indoors and maintain direct control of them. Prepare an emergency kit for your pets, including sturdy leashes or pet carriers, food and water, bowls, cat litter and pan, and photos of you with your pet in case they get lost.

Find more information on preparedness on redcross.org.

How to Help
The Red Cross depends on financial donations to be able to provide disaster relief immediately. Donations enable the Red Cross to prepare for, respond to and help people recover from disaster. Help people affected by Hurricane Irma by visiting redcross.org, calling 1- 800-RED CROSS or texting the word IRMA to 90999 to make a $10 donation.

CORPORATIONS HELP The generous donations from members of the Red Cross Annual Disaster Giving Program (ADGP) and the Disaster Responder Program enable the American Red Cross to prepare communities for disasters big and small, respond whenever and wherever disasters occur and help families during the recovery process.

ADGP $1 Million members are: American Airlines; Anheuser-Busch Foundation; Anthem Foundation; Bank of America; Caterpillar Foundation; The Clorox Company; Costco Wholesale; Delta Air Lines; Disney; Enterprise Rent-A-Car Foundation; FedEx; General Motors Foundation; Grainger; The Home Depot Foundation; LDS Charities; Lowe's Companies, Inc.; Mazda North American Operations; Microsoft Corp.; Nationwide Foundation; PepsiCo Foundation; State Farm; Target; UPS; VSP Global; Walmart and the Walmart Foundation; and The Wawa Foundation.

ADGP $500,000 members are: Altria Group; American Express; Aon; Boise Paper; Capital One; Cisco Foundation; Citi Foundation; Darden Restaurants, Inc. Foundation; Discover; Edison International; Farmers Insurance; Ford Motor Company; Humble Bundle; International Paper; John Deere Foundation; Johnson Controls; McDonald's Corporation; Medtronic Foundation; Meijer; Merck Foundation; Mondelēz International Foundation; Procter & Gamble Company; Reynolds American Foundation; Ryder; Southwest Airlines; Sunoco; TD Ameritrade; The TJX Companies, Inc.; United Airlines; and Wells Fargo.

Disaster Responder Program members are: Adobe; Alcoa; Alliance Data; Astellas USA Foundation; AT&T; AvalonBay Communities, Inc.; AXA; The Ball Foundation; BMW of North America; BNY Mellon; CarMax; Cox Automotive; Duke Energy; Entergy Corporation; Harbor Freight Tools Foundation; Hewlett Packard Enterprise Foundation; HP Foundation; IBM Corporation; IHG Foundation; Ingersoll Rand Foundation; The J.M. Smucker Company; Land O'Lakes, Inc.; Mastercard; Morgan Stanley; Neiman Marcus Group; New Balance Foundation; Northrop Grumman Corporation; Northwestern Mutual and the Northwestern Mutual Foundation; Prudential Foundation; SC Johnson; SERVPRO; Southeastern Grocers Home of BI-LO Harveys Winn Dixie; Standard Textile; Toyota; U-Haul International; United Technologies Corporation; The USAA Foundation; U.S. Bank; and Visa.

About the American Red Cross:
The American Red Cross shelters, feeds and provides emotional support to victims of disasters; supplies about 40 percent of the nation's blood; teaches skills that save lives; provides international humanitarian aid; and supports military members and their families. The Red Cross is a not-for-profit organization that depends on volunteers and the generosity of the American public to perform its mission. For more information, please visit redcross.org or cruzrojaamericana.org, or visit us on Twitter at @RedCross.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/red-cross-mobilizing-in-advance-of-historic-and-powerful-hurricane-irma-300515976.html

SOURCE American Red Cross

Red Cross Mobilizing in Advance of Historic and Powerful Hurricane Irma

Storm batters Caribbean and heads for Florida

WASHINGTON, Sept. 7, 2017 /PRNewswire-USNewswire/ -- The American Red Cross is mounting a massive response as Hurricane Irma — the most powerful Atlantic Ocean storm on record – remains a Category 5 hurricane with 175 mph winds expected to impact Florida as early as Friday. Irma has already caused destruction on many Caribbean island nations on its track toward the United States, and the Red Cross urges that those in the possible path of this storm monitor weather reports and get prepared or evacuate now.

In the Caribbean:
Hurricane Irma has already battered an estimated 1.2 million people in the Caribbean, and threatens millions more as it moves across the region. On the island of Barbuda, most of the buildings are damaged. Anguilla and St. Maarten also received major damage. Thousands of residents are without power and water, and there are major disruptions in phone and cell service. On Anguilla, the local Red Cross facility was severely damaged. In addition to the Red Cross Societies on the islands, numerous countries are helping, including the American Red Cross and Red Cross Societies in Canada, Italy, Spain, and Norway, as well as teams from the International Federation of the Red Cross and International Committee of the Red Cross.

In the U.S.:
In Puerto Rico and the U.S. Virgin Islands, some roads are damaged, phone and cell service is disrupted, and airports and ports are closed. In Puerto Rico, the Red Cross is on the ground helping and has sent in relief items such as blankets, personal hygiene items and cleaning supplies. More than half-a-million people are without power. More than 140 people spent Wednesday night in 20 shelters. On the U.S. Virgin Islands, almost 300 people spent Wednesday night in 6 shelters.

As the storm makes its way towards Florida, the Red Cross is getting supplies and trained workers in place to support sheltering and relief efforts.

  • The Red Cross is mobilizing hundreds of trained Red Cross disaster relief workers and is deploying truckloads of relief supplies.
  • Trailers of shelter supplies with enough cots and blankets for 120,000 people are on the way to help people impacted by Irma.
  • In addition, 100,000 ready-to-eat meals and as many as 120 emergency response vehicles are being mobilized.
  • The Red Cross is also working in close collaboration with government officials and community partners to coordinate potential response efforts.
  • In preparation for Hurricane Irma, the Red Cross has pre-positioned additional blood products in areas of the Southeast likely to be impacted by the storm over the upcoming days. Earlier this week, the Red Cross also shipped additional blood products to Puerto Rico to help ensure a sufficient supply remains available for our hospital partners on the island in the aftermath of this powerful storm.

Governors in Georgia, South Carolina and North Carolina have issued states of emergency for all three states, which could face impact from the storm sometime next week.

Hurricane Safety Steps
Find a shelter by visiting redcross.org or by downloading the free Red Cross Emergency App. The Emergency App also puts real-time information about the storm and hurricane safety tips at your fingertips. The app is available in app stores by searching for the American Red Cross or going to redcross.org/apps. You can also follow these safety steps:

Before the storm:

  • Continue listening to local area radio, NOAA radio or TV stations for the latest information and updates.
  • If your neighborhood is prone to flooding, be prepared to evacuate quickly if necessary.
  • Build an emergency kit that contains supplies for about three days.
  • Follow evacuation orders and do not attempt to return until officials say it is safe to do so.
  • Head for higher ground and stay there.
  • Stay away from floodwaters. If you come upon a flowing stream where water is above your ankles, stop, turn around and go another way.
  • Be especially cautious at night when it's harder to see flood danger.
  • Make sure you have a plan and supplies for your pets. Download the free Red Cross Pet First Aid App for emergency preparedness tips, a pet-friendly hotel locator and an animal hospital locator.

During the storm:

  • Stay indoors.
  • Don't walk on beaches, riverbanks or in flood waters.
  • Use flashlights in the dark if the power goes out. Do NOT use candles.
  • Turn off the power and water mains if instructed to do so by local authorities.
  • Don't forget your pets. Bring them indoors and maintain direct control of them. Prepare an emergency kit for your pets, including sturdy leashes or pet carriers, food and water, bowls, cat litter and pan, and photos of you with your pet in case they get lost.

Find more information on preparedness on redcross.org.

How to Help
The Red Cross depends on financial donations to be able to provide disaster relief immediately. Donations enable the Red Cross to prepare for, respond to and help people recover from disaster. Help people affected by Hurricane Irma by visiting redcross.org, calling 1- 800-RED CROSS or texting the word IRMA to 90999 to make a $10 donation.

CORPORATIONS HELP The generous donations from members of the Red Cross Annual Disaster Giving Program (ADGP) and the Disaster Responder Program enable the American Red Cross to prepare communities for disasters big and small, respond whenever and wherever disasters occur and help families during the recovery process.

ADGP $1 Million members are: American Airlines; Anheuser-Busch Foundation; Anthem Foundation; Bank of America; Caterpillar Foundation; The Clorox Company; Costco Wholesale; Delta Air Lines; Disney; Enterprise Rent-A-Car Foundation; FedEx; General Motors Foundation; Grainger; The Home Depot Foundation; LDS Charities; Lowe's Companies, Inc.; Mazda North American Operations; Microsoft Corp.; Nationwide Foundation; PepsiCo Foundation; State Farm; Target; UPS; VSP Global; Walmart and the Walmart Foundation; and The Wawa Foundation.

ADGP $500,000 members are: Altria Group; American Express; Aon; Boise Paper; Capital One; Cisco Foundation; Citi Foundation; Darden Restaurants, Inc. Foundation; Discover; Edison International; Farmers Insurance; Ford Motor Company; Humble Bundle; International Paper; John Deere Foundation; Johnson Controls; McDonald's Corporation; Medtronic Foundation; Meijer; Merck Foundation; Mondelēz International Foundation; Procter & Gamble Company; Reynolds American Foundation; Ryder; Southwest Airlines; Sunoco; TD Ameritrade; The TJX Companies, Inc.; United Airlines; and Wells Fargo.

Disaster Responder Program members are: Adobe; Alcoa; Alliance Data; Astellas USA Foundation; AT&T; AvalonBay Communities, Inc.; AXA; The Ball Foundation; BMW of North America; BNY Mellon; CarMax; Cox Automotive; Duke Energy; Entergy Corporation; Harbor Freight Tools Foundation; Hewlett Packard Enterprise Foundation; HP Foundation; IBM Corporation; IHG Foundation; Ingersoll Rand Foundation; The J.M. Smucker Company; Land O'Lakes, Inc.; Mastercard; Morgan Stanley; Neiman Marcus Group; New Balance Foundation; Northrop Grumman Corporation; Northwestern Mutual and the Northwestern Mutual Foundation; Prudential Foundation; SC Johnson; SERVPRO; Southeastern Grocers Home of BI-LO Harveys Winn Dixie; Standard Textile; Toyota; U-Haul International; United Technologies Corporation; The USAA Foundation; U.S. Bank; and Visa.

About the American Red Cross:
The American Red Cross shelters, feeds and provides emotional support to victims of disasters; supplies about 40 percent of the nation's blood; teaches skills that save lives; provides international humanitarian aid; and supports military members and their families. The Red Cross is a not-for-profit organization that depends on volunteers and the generosity of the American public to perform its mission. For more information, please visit redcross.org or cruzrojaamericana.org, or visit us on Twitter at @RedCross.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/red-cross-mobilizing-in-advance-of-historic-and-powerful-hurricane-irma-300515976.html

SOURCE American Red Cross

Cota Appoints Elizabeth Rushforth, Former SVP and Legal Counsel at MedeAnalytics, as Chief Legal Officer

NEW YORK, Sept. 7, 2017 /PRNewswire/ -- Cota, Inc., a healthcare data and analytics company that bridges precision medicine to population health, today announced that Elizabeth Rushforth will join as Chief Legal Officer, serving as the primary counsel and legal expert for Cota. Rushforth has deep experience in several areas of law, including securities, regulatory and compliance. Rushforth was most recently the Chief Legal Officer for Sungevity, a technology-driven solutions provider and spent three years at MedeAnalytics as SVP and General Counsel.

"We are excited to welcome Elizabeth on board as we reach a major inflection point in the company," said John Hervey, Cota's Chief Executive Officer. "She brings a valuable set of legal experience and leadership skills that will be an asset to us as we expand and advance our offerings to the payer, provider and life science community."

Rushforth has deep experience in the areas of securities law, regulatory compliance, corporate governance, mergers and acquisitions, financial market transactions, transactional and employment law, as well as litigation. She has held a number of senior positions with fast-growing, technology-driven companies over her 17-year career, and joins Cota from MedeAnalytics, Inc., a cloud-based software analytics business, where she served as Senior Vice President and General Counsel. Prior to that, she served as Vice President, General Counsel and Corporate Secretary at UnwiredPlanet, Inc.

"I am excited to join the Cota executive leadership team and have a deep appreciation for their real-world evidence and data analytics capabilities," said Rushforth. "I look forward to helping make that model as strong and effective as possible by, among other things, developing best practices and compliance functions that drive value to the company, its partners, its shareholders and its customers."

In addition to Rushforth, the following leadership changes and new appointments are effective immediately:

  • Thomas L. Gallucci will join as Chief Financial Officer and is responsible for managing Cota's finances, overseeing related business segments and contributing to the strategic direction of the company. Most recently, Gallucci was a Managing Director at Cain Brothers where he focused on merger and acquisitions within the healthcare services sector and brings over 20 years of healthcare industry experience to Cota.
  • Emmet O'Gara will join as Senior Vice President and Chief Revenue Officer and is responsible for business development and account management activities. O'Gara has spent the past eight years at MedeAnalytics, most recently as Senior Vice President and General Manager of Payer and Provider Solutions. O'Gara brings over 25 years of strategic Payer market experience to Cota.
  • Ann Collins will join as Senior Vice President of Pharmacutical and Life Sciences Strategy and is responsible for Cota's life sciences and pharma solutions for driving the clinical vision and strategy. Collins, who has over 20 of years in life sciences and oncology, previously held leadership roles at Vion, Agios and Schering Plough and is trained as an oncology physician associate.
  • Janhvi Patel will join as Vice President of Strategic Partnerships, and is responsible for managing and cultivating Cota's partnerships like the collaboration with IBM Watson for Oncology. Previously, Patel was with IBM Watson Health in Strategic Partnerships.
  • K. Marinka Natale will join as Vice President of Payer-Provider Solutions and is responsible for Cota's Payer product vision and strategy. Natale, who has 15 years of healthcare informatics experience on the payer side, was most recently Senior Director of Informatics – Data Science at Aetna.
  • Eva Werk will join as Vice President of Marketing and will oversee all marketing and communication activities at Cota. Most recently, Werk spent three years at Saffron Technology, an AI data analytics software company acquired by Intel Corp.

About Cota, Inc.
Cota, Inc. is a technology platform that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.

Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com

Media Contact:
Victoria Khamsombath
SHIFT Communications
Cota@SHIFTcomm.com   
415.591.8464

View original content with multimedia:http://www.prnewswire.com/news-releases/cota-appoints-elizabeth-rushforth-former-svp-and-legal-counsel-at-medeanalytics-as-chief-legal-officer-300515949.html

SOURCE Cota

Tom Gallucci, Former Cain Brothers Managing Director, Joins Cota as Chief Financial Officer

NEW YORK, Sept. 7, 2017 /PRNewswire/ -- Cota, Inc. a healthcare data and analytics company that bridges precision medicine to population health, today announced that Thomas L. Gallucci has joined as Chief Financial Officer. Gallucci is responsible for managing Cota's finances, overseeing related business segments and contributing to the strategic direction of the business. He brings over two decades of healthcare industry and finance experience to Cota, both as a leading equity research analyst and investment banker. Most recently, Gallucci was a Managing Director at Cain Brothers where he focused on strategic advisory and M&A services within the healthcare sector.

"Tom shares our vision and commitment to creating solutions and offerings that help industry stakeholders provide individual patients the most optimal care," said John Hervey, Cota's Chief Executive Officer. "I am thrilled to welcome him to the leadership team. His healthcare-specific background and business acumen are a critical asset to growing and expanding the company."

Prior to Cain Brothers, Gallucci spent the bulk of his career at Merrill Lynch and Lazard Capital Markets as an equity research analyst focused on healthcare services.  Among other awards and recognition, he was named to the Institutional Investor All-America team six times overall, and once, uniquely, in two separate categories. He started in healthcare equity research in 1995 at Credit Suisse First Boston and was with Bear Stearns from 1996 to 1999. Prior to that, he worked at Ernst & Young. Gallucci earned a B.S. with High Honors in accounting from Lehigh University.

"I am very pleased to be given the opportunity to join an exceptional group of people on the important mission of improving healthcare," said Gallucci. "The practice of more precise medicine is long overdue, but the healthcare system is finally ready and Cota is well-positioned to make it a reality. It is generally an exciting time for everyone involved in healthcare and I look forward to leveraging my experience to help Cota succeed in driving change across the continuum, ultimately to the benefit of patients."

In addition to Gallucci, the following leadership changes and new appointments are effective immediately:

  • Elizabeth Rushforth will join as Chief Legal Officer, serving as the primary counsel and legal expert for Cota. Rushforth has deep experience in several areas of law, including securities, regulatory and compliance. Rushforth was most recently the Chief Legal Officer for Sungevity, a technology-driven solutions provider and spent 3 of years at MedeAnalytics as SVP and General Counsel.
  • Emmet O'Gara will join as Senior Vice President and Chief Revenue Officer and is responsible for business development and account management activities. O'Gara has spent the past eight years at MedeAnalytics, most recently as Senior Vice President and General Manager of Payer and Provider Solutions. O'Gara brings over 25 years of strategic Payer market experience to Cota.
  • Ann Collins will join as Senior Vice President of Pharmaceutical and Life Sciences Strategy and is responsible for Cota's life sciences and pharma solutions and driving the clinical vision and strategy. Collins, who has over 20 of years in life sciences and oncology, previously held leadership roles at Vion, Agios and Schering Plough and is trained as an oncology physician associate.
  • Janhvi Patel will join as Vice President of Strategic Partnerships, and is responsible for managing and cultivating Cota's partnerships like the collaboration with IBM Watson for Oncology. Previously, Patel was with IBM Watson Health in Strategic Partnerships.
  • K. Marinka Natale will join as Vice President of Payer-Provider Solutions and is responsible for Cota's Payer product vision and strategy. Natale, who has 15 years of healthcare informatics experience on the payer side, was most recently Senior Director of Informatics – Data Science at Aetna.
  • Eva Werk will join as Vice President of Marketing and will oversee all marketing and communication activities at Cota. Most recently, Werk spent three years at Saffron Technology, an AI data analytics software company acquired by Intel Corp.

About Cota, Inc.
Cota, Inc. is a technology platform that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.

Cota's technology enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and medicine to improve the lives of patients everywhere. For more information, go to www.cotahealthcare.com

Media Contact:
Victoria Khamsombath
SHIFT Communications
Cota@SHIFTcomm.com   
415.591.8464

 

View original content with multimedia:http://www.prnewswire.com/news-releases/tom-gallucci-former-cain-brothers-managing-director-joins-cota-as-chief-financial-officer-300515954.html

SOURCE Cota

West Cancer Center and the University of Tennessee Health Science Center Welcome D. Neil Hayes, MD, MPH, to Lead The Cancer Research Initiative

Dr. Hayes to serve as Scientific Director, Medical Oncologist and the Van Vleet Endowed Professor

MEMPHIS, Tenn., Sept. 7, 2017 /PRNewswire-USNewswire/ -- West Cancer Center and the University of Tennessee Health Science Center (UTHSC), in partnership with St Jude Children's Research Hospital are proud and excited to announce the appointment of D. Neil Hayes, MD, MPH, as the Scientific Director of the UT-West Institute for Cancer Research, and the Van Vleet Endowed Professor in Medical Oncology in the Department of Medicine (Division of Hematology-Oncology) with secondary appointments in the Department of Genetics, Genomics, and Informatics (GGI) and the Department of Preventive Medicine in the College of Medicine (COM) of the University of Tennessee Health Science Center (UTHSC). Through these leadership roles and appointments, Dr. Hayes will direct and drive funding to lead scientific initiatives for discovery in translational research for the advancement of novel cancer treatment and therapies.

Dr. Hayes will assume direction of a $25 million dollar fund raised through the combined efforts of The West Cancer Center, University of Tennessee Health Science Center and Methodist Le Bonheur Health Care. He will utilize this fund to recruit additional scientists to the UT / West Institute for Cancer Research in service of a unique program of precision cancer medicine. West Cancer Center's ultimate goal is to become an NCI designated cancer center, which is anticipated to take seven to ten years with an additional investment of $100 million.  "Dr. Hayes will lead the scientific research and discovery portion of this journey, specifically launching a program to recruit scientists focused on genomic research for the development of more personalized cancer care," replied Dr. Lee Schwartzberg, the Executive Director of the West Cancer Center.

The recruitment of Dr. Hayes was a collaboration between healthcare leaders within the partnership and St Jude Children's Research Hospital.  "Our goal was to attract Neil because of his strong background in cancer genomics and his goal of moving genomic paradigms to clinical decision making. This molecular focus that involves bringing the result to the patient is the forefront of precision/personalized medicine in cancer and other areas. He will be the focus of this approach on the UTHSC campus and at West Cancer Center," stated Dr. David Stern, Robert Kaplan Executive Dean for the College of Medicine at UTHSC.  

Dr. Hayes most recently served as co-leader of the University of North Carolina (UNC) Lineberger Clinical Research Program, Professor in the Division of Hematology/Oncology and the Department of Otolaryngology/Head and Neck Cancer Surgery, and director of Clinical Bioinformatics at UNC. During his tenure at UNC Lineberger – a National Cancer Institute (NCI) Designated Comprehensive Cancer Center – Dr. Hayes successfully garnered over $40 million dollars in cancer research grants and funding, while simultaneously developing one of the most productive clinical trial programs for head and neck cancer in the nation. More broadly, Dr. Hayes currently is in his 10th year as a leader in efforts surrounding the Cancer Genome Atlas (TCGA), the pivotal genomic sequencing project of the decade. His most notable accomplishments in this area include co-leading the sequencing of RNA for most of the project, and a senior role in more than 20 manuscripts reported in Cell, Nature, and the New England Journal.  Dr. Hayes lists over 120 peer-reviewed manuscripts in the last decade in the field of cancer research and is most proud of his trainee record including more than 30 students and post-doctoral fellows. While at UNC Lineberger Clinical Research Program, Dr. Hayes began work in molecular profiling in lung and head and neck cancer that shows a wide range of potential clinical utility, including the ability to predict clinical outcomes for which there are currently no existing clinical diagnostic tests

Dr. Hayes will share his expertise with the next generation of cancer providers and scientists at UTHSC, where he will have a primary appointment as a professor in the Department of Internal Medicine, Division of Hematology/Oncology, and secondary appointments as a professor in the Department of Genetics, Genomics, and Informatics, and the Department of Preventive Medicine.  In terms of his collaboration with St. Jude, Dr. Hayes experience with gene expression and RNA analysis brings a unique skill set to the classification of tumors of any etiology.  We look forward to collaborations that leverage both his specific expertise as well as his broad experience in genomics and team science. Board certified in medical oncology, hematology and internal medicine, Dr. Hayes earned his medical degree from the top-rated University of North Carolina in Chapel Hill, NC. He completed his residency at Boston University School of Medicine and a clinical fellowship at Tufts England Medical Center, continuing his education with a postdoctoral fellowship at the NCI Designated Dana Farber Cancer Institute in Boston, Massachusetts. Dr. Hayes also holds a Master's of Public Health from Harvard School of Public Health and a Master's of Science from Tufts New England School of Medicine.

As he looks forward, however, Dr. Hayes stated his hopes to continue his work and pursue further cancer research initiatives at the UT/West Institute of Cancer Research with a hunger for revolutionary discovery. "While I stand proudly behind a record of success in my years at UNC, my enthusiasm for the future dwarfs the accomplishments to date."  

About the University of Tennessee/ West Institute for Cancer Research
The University of Tennessee/ West Institute for Cancer Research is a not-for-profit public charity dedicated to raising funds for adult cancer research. Located in Memphis, TN, the UT/West Institute for Cancer Research solicits grants (from government agencies, foundations and individuals) to be utilized to broaden cutting-edge research programs, develop novel cancer treatments and therapeutics, and strengthen patient-focused care in all sectors of the community. Funds donated to the UT/West Institute are designated for research in five major areas of emphasis: Translational Drug Discovery and Development, Cancer Immunotherapy, Women's Cancers, Community Outcomes and WINGS Supportive Care. The generous philanthropy of our donors and benefactors provides the necessary funding for West Cancer Center researchers to create and produce the most effective therapies for cancer patients, with the collective goal of defeating cancer in its entirety.

About West Cancer Center
West Cancer Center delivers the best comprehensive cancer treatment in the Mid-South, delivering a complete continuum of care to over 30,000 individuals annually. A true leader in cancer research, West Cancer Center has a long standing commitment to providing patients access to clinical trials which includes Phase I through Phase III studies. Building on the 35 year legacy of West Clinic, West Cancer Center continues to provide comprehensive, compassionate care to the Mid-South area. This commitment is strengthened through a robust partnership with Methodist Healthcare and the University of Tennessee Health Science Center.

For more information, please visit: www.westcancercenter.org.

About University of Tennessee Health Science Center 
As Tennessee's only public, statewide, academic health system, the mission of the University of Tennessee Health Science Center (UTHSC) is to bring the benefits of the health sciences to the achievement and maintenance of human health, with a focus on the citizens of Tennessee and the region, by pursuing an integrated program of education, research, clinical care, and public service. Offering a broad range of postgraduate and selected baccalaureate training opportunities, the main UTHSC campus is located in Memphis and includes six colleges: Dentistry, Graduate Health Sciences, Health Professions, Medicine, Nursing and Pharmacy. UTHSC also educates and trains cohorts of medicine, pharmacy and/or health professions students -- in addition to medical residents and fellows -- at its major sites in Knoxville, Chattanooga and Nashville. Founded in 1911, during its more than 100 years, UT Health Science Center has educated and trained more than 57,000 health care professionals in academic settings and health care facilities across the state. For more information, visit www.uthsc.edu. Follow us on Facebook: facebook.com/uthsc, on Twitter: twitter.com/uthsc and on Instagram: instagram.com/uthsc. 

CONTACT:
West Cancer Center
Caitlin McCaskill
901.683.0055 ext. 61174
cmccaskill@westclinic.com

 

View original content:http://www.prnewswire.com/news-releases/west-cancer-center-and-the-university-of-tennessee-health-science-center-welcome-d-neil-hayes-md-mph-to-lead-the-cancer-research-initiative-300515964.html

SOURCE West Cancer Center

BrightStar Care Named 2017 Enterprise Champion for Quality Award For 5th Year

World's Premier Home Care Franchise Receives Honor from The Joint Commission

OAKBROOK TERRACE, Ill., Sept. 7, 2017 /PRNewswire/ -- BrightStar Care, a national private duty home care and medical staffing franchise with more than 300 locations nationwide, was awarded The Joint Commission's 2017 Enterprise Champion for Quality Award, honoring the brand's dedication to meeting the highest standards in in-home care. BrightStar Care is the only organization to achieve the title five years in a row and one of only two franchisors to receive this honor since the award's inception in 2013.

In order to qualify for the Enterprise Champion for Quality Award, a franchisor must demonstrate that a minimum of 95 percent of its franchisees are accredited and in good standing with the Joint Commission, the nation's oldest and largest standard-setting and accrediting body in healthcare that accredits some of the nation's most well-respected health systems.

"The Joint Commission commends BrightStar Care for not only achieving this prestigious recognition and the high level of quality that it represents — but also doing so for five consecutive years," said Margherita Labson, RN, executive director, Home Care Accreditation Program, The Joint Commission. "An ongoing commitment to excellence in home care for clients and their families is clearly demonstrated through BrightStar franchisees' work to maintain rigorous Joint Commission accreditation requirements. Such commitment and performance is a model for the field in the pursuit of the highest standards of patient safety and care delivery." 

"We're honored to be awarded The Joint Commission's Enterprise Champion for Quality Award for the fifth consecutive year, which is a testament to the hard work of our outstanding franchisees, as well as their nurses and caregivers," said Sharon Roth Maguire, MS, RN, GNP-BC, chief clinical quality officer of BrightStar Care. "This achievement emphasizes BrightStar Care's commitment to offer exceptional care and services to our clients, their families, and our healthcare system partners following the highest standards in the industry for care and safety."

BrightStar Care provides the full continuum of home care services comprised of companionship, personal care, dementia care, transportation, medication assistance, skilled nursing and more to improve clients' health and quality of life.

For more information on BrightStar Care please visit www.brightstarcare.com.

For more information on The Joint Commission, please visit www.jointcommission.org.

About BrightStar Care
Based in Chicago, BrightStar Care is a national private duty home care and medical staffing franchise with more than 300 locations which provide medical and non-medical services to clients within their homes, as well as supplemental care staff to corporate clients. BrightStar Care franchise locations across the country employ over 2,500 registered nurses who play a unique role in overseeing the care for each individual client, a service that no other private duty home care provider offers. In addition, BrightStar Care is the only national home care franchise to receive The Joint Commission's Enterprise Champion for Quality award every year since the award's inception. In 2015, the company ranked No. 177 on Entrepreneur Magazine's Franchise 500 list, No. 27 on Crain's Chicago "Fast Fifty," ranking and was included for the tenth consecutive year on Inc. Magazine's prestigious Inc. 5000 list.

About The Joint Commission
Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies nearly 21,000 health care organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at www.jointcommission.org.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/brightstar-care-named-2017-enterprise-champion-for-quality-award-for-5th-year-300515961.html

SOURCE BrightStar Care